Common therapeutic advances for Duchenne muscular dystrophy (DMD)

A Salmaninejad, Y Jafari Abarghan… - International Journal …, 2021 - Taylor & Francis
Background and purpose: Duchenne muscular dystrophy (DMD), a lethal X-linked recessive
muscle dystrophy, is resulted in by different mutations including mostly frame-shifting gross …

Common therapeutic advances for Duchenne muscular dystrophy (DMD).

A Salmaninejad, H Bayat, M Yousefi… - The International …, 2020 - europepmc.org
Background and purpose: Duchenne muscular dystrophy (DMD), a lethal X-linked recessive
muscle dystrophy, is resulted in by different mutations including mostly frame-shifting gross …

Common therapeutic advances for Duchenne muscular dystrophy (DMD)

A Salmaninejad, YJ Abarghan… - The International …, 2021 - pubmed.ncbi.nlm.nih.gov
Background and purpose: Duchenne muscular dystrophy (DMD), a lethal X-linked recessive
muscle dystrophy, is resulted in by different mutations including mostly frame-shifting gross …

[引用][C] Common therapeutic advances for Duchenne muscular dystrophy (DMD)

A Salmaninejad, YJ Abarghan, SB Qomi… - International Journal of …, 2020 - hero.epa.gov
Common therapeutic advances for Duchenne muscular dystrophy (DMD) | Health &
Environmental Research Online (HERO) | US EPA Jump to main content US EPA United States …

[引用][C] Common therapeutic advances for Duchenne muscular dystrophy (DMD)

A Salmaninejad, YJ Abarghan, SB Qomi… - International Journal of …, 2020 - cir.nii.ac.jp
Common therapeutic advances for Duchenne muscular dystrophy (DMD) | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

[引用][C] Common therapeutic advances for Duchenne muscular dystrophy (DMD)

A Salmaninejad, YJ Abarghan, SB Qomi, H Bayat… - International Journal of …, 2020

[引用][C] Common therapeutic advances for Duchenne muscular dystrophy (DMD)

A Salmaninejad, YJ Abarghan, SB Qomi, H Bayat… - International Journal of …, 2020